METHENOLONE ENANTHATE INJECTION 100mg/ml

COMPOSITION:
Each ml contains:
Methenolone Enanthate 100 mg

PHARMACOLOGICAL ACTION:
Methenolone Enanthate is an injectable anabolic prepara on. After injection, Methenolone Enanthate is gradually released from the intramuscular depot and subsequently hydrolysed into nandrolone.

INDICATIONS:
Methenolone Enanthate should be used with cau on in pa ents with any disease, especially cancer of the prostate or breast, liver, heart. Kidney disease, allergy, enlarged prostate. High dosage, long term use of androgens has been related to liver cancer. This drug should not be used during pregnancy or lacta on. Females should be monitored for signs viriliza on, such as deepening of the voice. facial haft, acne, menstrual irregularity or clitoral enlargement, consult the doctor promptly if any of these symptoms occur. Use in children should not be recommended due to the possibility this drug may have undesirable effects related to the growth of the child. It should be used with extreme cau on in geriatric men because they are at higher risk for developing enlarged prostates or prostate cancer when using this medica on.

CONTRA-INDICATIONS:
Not intended for use in children.
Known or suspected prosta c carcinoma and mammary carcinoma in the male.
Not intended for use in female pa ents other than those with disseminated breast cancer.
Contraindicated in nephrosis or the nephrotic phase of nephritis, cardiac and renal failure, hypercalcaemia, oedema, jaundice, liver disease with impaired bilirubin excretion, testicular and hepatic carcinoma.

DOSAGE AND DIRECTIONS FOR USE:
Methenolone Enanthate should be administered by deep intramuscular injection.
Adult dose: 50-100 mg every 3 weeks.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Virilisa on which appears in sensitive women as hoarseness, acne, hirsutism, and increased libido; in prepubertal boys as an increased frequency of erections and phallic enlargement, and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change which may end in a long-las ng, some mes irreversible deepening of the voice.

OTHER ADVERSE REACTIONS MAY INCLUDE:
Oligospermia and decreased ejaculatory volume;
Suppression of ovarian ac vity, atrophy of the breasts and endometrial  ssue.
Amenorrhoea and inhibi on of spermatogenesis.
Water and salt reten on.
Premature epiphyseal closure.
If signs of virilisa on develop, treatment should be discon nued.
Increase in nitrogen reten on and skeletal weight;
Oedema;
Increased vascularity of the skin;
Increased growth of the bone;
Elderly males may become over-s mulated.